Report in English with a Dutch summary (KCE reports 45A)

KCE reports vol.45 Screening for Colorectal Cancer 225
140. Benhamiche-Bouvier AM, Lejeune C, Jouve JL, Manfredi S, Bonithon-Kopp C, Faivre
J. Family history and risk of colorectal cancer: implications for screening
programmes. J Med Screen. 2000;7(3):136-40.
141. Rex D. Should we colonoscope women with gynecologic cancer? American Journal
of Gastroenterology. 2000;95(3):812-3.
142. Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial
colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention. 2001;10(7):793-8.
143. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the
familial relative risk of cancer by site from a French population based family study on
colorectal cancer (CCREF study). Gut. 2004;53(9):1322-8.
144. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. Lower cancer
incidence in Amsterdam-I criteria families without mismatch repair deficiency:
familial colorectal cancer type X. JAMA. 2005;293(16):1979-85.
145. Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of
revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for
the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA.
2005;293(16):1986-94.
146. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal
cancer risk. Am J Gastroenterol. 2001;96(10):2992-3003.
147. AHRQ. Screening for Colorectal Cancer In Adults - Systematic Evidence Review.
AHRQ Publication No. 02-S003. 2002.
148. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal
cancer for individuals with a family history: a meta-analysis. Eur J Cancer.
2006;42(2):216-27.
149. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al.
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology.
1997;112(2):594-642.
150. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, et al.
Risk of colorectal cancer in the families of patients with adenomatous polyps.
National Polyp Study Workgroup. N Engl J Med. 1996;334(2):82-7.
151. Weinberg DS, Newschaffer CJ, Topham A. Risk for colorectal cancer after
gynecologic cancer. Annals of Internal Medicine. 1999;131(3):189-93.
152. Eisen GM, Sandler RS. Are women with breast cancer more likely to develop
colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol.
1994;19(1):57-63.
153. Kewenter J, Haglind E, Smith L. Value of a risk questionnaire in screening for
colorectal neoplasm. Br J Surg. 1989;76(3):280-3.
154. Ruo L, Cellini C, La-Calle JP, Jr., Murray M, Thaler HT, Quan SH, et al. Limitations of
family cancer history assessment at initial surgical consultation. Diseases of the
Colon & Rectum. 2001;44(1):98-103; discussion -4.
155. Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous ME. Colonoscopy
surveillance of individuals at risk of familial colorectal cancer. Gut. 2003;52(12):1748-
51.
156. Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, et al.
Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53(2):291-5.
157. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening
for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). New England
Journal of Medicine. 2005;352(18):1851-60.
158. Hurlstone DP, Karajeh M, Cross SS, McAlindon ME, Brown S, Hunter MD, et al. The
role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis
colorectal cancer screening: a prospective "back-to-back" endoscopic study.
American Journal of Gastroenterology. 2005;100(10):2167-73.